Please login to the form below

Not currently logged in
Email:
Password:

Pharma urged to tackle non-compliance

The pharma industry must act to combat patient non-compliance, which averages at 50 per cent for long-term conditions, such as HIV and arthritis, according to a Capgemini report

The pharma industry must act to combat patient non-compliance, which averages at 50 per cent for long-term conditions, such as HIV and arthritis, according to a Capgemini report.

The report estimates that patient non-adherence to prescribed medicine courses is responsible for 194,500 deaths per year in the EU and 131,400 deaths per year in the US. Nonadherence results in annual costs of close to €125bn in the EU and $300bn in the US.

Jean-Marc Neimetz, global leader of the life sciences practice Capgemini Consulting, said: "The pharmaceutical industry needs to address patient adherence in a more strategic and integrated part of its activities, which will be good for the patients and for the industry overall."

They need to design and deploy programmes targeted to the very specific patient situations and leverage both traditional and digital approaches to do so, added Thomas Forissier, a principal of the life sciences practice at Capgemini Consulting.

The report said that almost all chronic conditions face high rates of non-adherence and those with no visible symptoms, such as depression, have the lowest adherence rates. The problem even extends to oral formulation chemotherapy drugs, where there is less expectation to counter patient adherence issues due to the seriousness of the condition. As much as 40 per cent of cancer patients are non-adherent in this case.

2nd June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics